School of Engineering
Showing 381-400 of 557 Results
-
Patrick Lee Purdon
Professor of Anesthesiology, Perioperative and Pain Medicine (Department Research) and, by courtesy, of Bioengineering
BioMy research integrates neuroimaging, biomedical signal processing, and the systems neuroscience of general anesthesia and sedation.
We are a neuroengineering lab focused on brain dynamics, brain health, and the neural mechanisms of anesthesia. Our research aims to understand the brain dynamics of aging, Alzheimer’s disease, child development, sleep, anesthesia, and consciousness. We use this knowledge to develop novel technologies for brain monitoring and physiological control. We also teach anesthesiologists how to use EEG to provide personalized anesthesia care. -
Stanley Qi
Associate Professor of Bioengineering and, by courtesy, of Biomedical Data Science
BioStanley Qi (publishing as Lei S. Qi) is a pioneer in the field of genome engineering and the architect of the foundational technologies that transitioned CRISPR from a "cutting" tool into a universal platform for Programmable Biology. As the inventor of CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa), Qi established the first methods for the precise, reversible, and targeted regulation of the human genome without altering the DNA sequence.
The Qi Lab integrates scalable genomic perturbation with live-cell and super-resolution imaging and computation-guided design to redefine the boundaries of cellular control. Under Dr. Qi’s leadership, the group has fundamentally expanded the genome engineering toolbox, evolving CRISPR from a single editing tool into a multidimensional platform for the precise control of dynamic and spatial cell states. This work includes establishing foundational technologies and architectures for precise epigenetic editing, multiplexed regulation of the transcriptome, programmable 3D genome organization, and spatial control of RNA logistics. By pioneering real-time visualization of chromatin dynamics and RNA in living cells, the lab provides an unprecedented window into the fundamental "control principles of life."
This principle-driven technology lineage has moved into the clinic, with the lab's compact epigenetic editor currently in first-in-human clinical testing for FSHD muscular dystrophy (NCT06907875). This milestone represents a core mission of the lab: translating foundational engineering into next-generation therapeutics that act predictably as dynamic, complex systems.
Beyond single-cell control, the Qi Lab is building a framework for synthetic cell–cell communication, with a particular emphasis on the bidirectional interplay between immune cells and neurons. The lab’s goal is to move beyond describing molecular parts to discovering fundamental control principles in living systems: how regulatory landscapes create stable states and memory, how spatial genome–RNA organization shapes dynamic responses, and how engineered cell–cell interactions can generate emergent multicellular behaviors.
By integrating computational design with experimental biology, Dr. Qi aims to identify the generalizable rules linking molecular programs to systems-level physiology. He is a Chan Zuckerberg Biohub Investigator and an Institute Scholar at the Sarafan ChEM-H, and is dedicated to shaping the technical and ethical frameworks that will define the future of human genome engineering. -
Stephen Quake
Lee Otterson Professor in the School of Engineering and Professor of Bioengineering, of Applied Physics and, by courtesy, of Physics
On Leave from 2026-10-01 To 2027-06-30Current Research and Scholarly InterestsSingle molecule biophysics, precision force measurement, micro and nano fabrication with soft materials, integrated microfluidics and large scale biological automation.
-
Akshita Rao
Ph.D. Student in Bioengineering, admitted Autumn 2022
Current Research and Scholarly InterestsMultimodal electrophysiology, sleep neuroscience
-
Mark Christian Reynolds
Academic Program Professional, Program-Jewett, M.
Current Role at StanfordAcademic Program Professional (School of Engineering)
-
Luca Rosalia
Postdoctoral Scholar, Bioengineering
BioLuca Rosalia received his bachelor’s and master’s degrees in Biomedical Engineering from the University of Glasgow (UK). During his studies, he visited the National University of Singapore and the University of Cambridge, where he gained his first exposure to the fields of soft robotics and tissue biomechanics. He pursued doctoral studies in the Health Sciences and Technology (HST) Ph.D. program of Harvard University and Massachusetts Institute of Technology in the lab of Ellen Roche and he's currently at Stanford University as a Postdoctoral Scholar in Bioengineering in the Skylar-Scott lab.
His doctoral work primarily focused on high-fidelity and patient-specific soft robotic preclinical models of valvular heart disease, congenital defects, and heart failure with preserved ejection fraction. Luca leveraged these platforms for the testing and development of medical devices through several partnerships with industry. During his studies, he also worked as an R&D engineer in the Structural Heart division of Abbott Laboratories on the development of transcatheter aortic valve replacements (TAVR). He also gained clinical experience at the Veterans Affairs Medical Center in Boston and at Boston Children's Hospital. In the Skylar-Scott lab, Luca will be working on whole-heart bioprinting.
